Back to BARCLAYS PLC BARCLAYS PLC

AVIRAVIR
Showing 8 of 18 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in ATEA PHARMACEUTICALS INC

BARCLAYS PLC holds 348,653 shares of AVIR (ATEA PHARMACEUTICALS INC), worth $1.6M as of 2026-Q2. The position was increased (+116.6% shares). AVIR represents 0.0% of BARCLAYS PLC's portfolio.

Current Value

$1.6M

Current Shares

348,653

Total Value Change

+$1M

Total Shares Change

+171,576

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
348,653
+116.6%
$1.6M0.0%$4.65
41
2026-Q1
Decreased
160,946
-33.8%
$865,8890.0%$4.82
0
2025-Q4
Increased
242,990
+0.6%
$867,4740.0%$3.55
25
2025-Q3
Decreased
241,464
-7.8%
$700,2460.0%$2.92
0
2025-Q2
Increased
261,774
+52.8%
$942,3860.0%$3.45
35
2025-Q1
Decreased
171,312
-14.4%
$512,2240.0%$2.93
0
2024-Q4
Increased
200,113
+13.0%
$670,3790.0%$3.33
28
2024-Q3
Increased
177,077
+74.5%
$593,2080.0%$3.44
37

Other major holders of AVIR: RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used